Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

Sponsors and Collaborators
Ferring Pharmaceuticals

Contact
Clinical Development Support
DK0-Disclosure@ferring.com

Principal Investigator
Clinical Development Support, Ferring Pharmaceuticals

ClinicalTrials.gov Identifier
NCT01729676

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters